RE: 2 many old tests leftover19 May 2021 12:19
Ok BIL, we see it differently. I see the "market" as made up of people who buy and sell and that price moves are made up of supply & demand. Not a random glob of MM's constantly manipulating the price.
Yes, I am saying the SP has poorly performed in the last 12 months, given the market that AVCT inhabit and its proposed product range, and its not irrelevant because if we can understand better why that is, it might lead to more accurate expectation going forward.
For instance my "journey" over the last nearly 12 months is one of expectation of immediate results to a realisation that AS is to be ignored on any timeline he gives, to then realise that AVCT is a much longer play now that I originally expected (and I am referring to now, all the cancer treatments). It will be 2-5 years I think. if its sooner great, but so far AVCT is in fact it would seem, typical of a bio pharma.- high risk, and nothing happens as quickly as one would hope.
And that's ok and as you can say I can either wait or sell, but we can still discuss it to pass the time can't we?